Summary
Ecolab Inc. reported net sales of $3.58 billion for the first quarter ended March 31, 2020, a 2% increase year-over-year. The company's operating income also saw a healthy increase of 8% to $397.2 million. Despite a 4% decrease in net income attributable to Ecolab to $283.4 million and a slight dip in diluted EPS to $0.97, the company demonstrated resilience amidst a challenging economic environment, likely impacted by the early stages of the COVID-19 pandemic and significant events in the energy markets. The company highlighted increased sales in its Global Industrial, Global Institutional, and Global Healthcare & Life Sciences segments, though the Upstream Energy segment experienced a decline. Significant "special charges" were noted, primarily related to the planned separation of the Upstream Energy business and restructuring activities, which impacted net income. Ecolab maintained a strong liquidity position with $1.66 billion in cash and cash equivalents, and continues to execute its strategic objectives, including an agreement to acquire CID Lines, expected to close in the second quarter of 2020.
Financial Highlights
55 data points| Revenue | $3.02B |
| Cost of Revenue | $1.72B |
| Gross Profit | $1.30B |
| SG&A Expenses | $908.30M |
| Operating Income | $376.20M |
| Interest Expense | $52.50M |
| Net Income | $283.40M |
| EPS (Basic) | $0.98 |
| EPS (Diluted) | $0.97 |
| Shares Outstanding (Basic) | 288.80M |
| Shares Outstanding (Diluted) | 292.60M |
Key Highlights
- 1Net sales increased by 2% to $3.58 billion compared to the prior year's first quarter.
- 2Operating income rose by 8% to $397.2 million, demonstrating operational efficiency.
- 3The company maintained a strong cash position, ending the quarter with $1.66 billion in cash and cash equivalents.
- 4Significant "special charges" totaling $61.5 million were incurred, largely due to the planned ChampionX separation and restructuring activities, impacting net income.
- 5Sales growth was observed in Global Industrial, Global Institutional, and Global Healthcare & Life Sciences segments, while Upstream Energy sales decreased by 3%.
- 6Ecolab announced an agreement to acquire CID Lines, expected to close in Q2 2020, reflecting continued strategic growth initiatives.
- 7Diluted EPS decreased slightly to $0.97, reflecting the impact of special charges and other factors.